Qualcomm, antitrust guidelines, AAP, motions to transfer venue, Biogen, TTAB, Samsung v Apple – the week in IP

An FTC complaint against Qualcomm, new antitrust guidelines for the licensing of intellectual property, Maria Pallante's new job at the Association of American Publishers, data on motions to transfer venue in patent cases, and Biogen’s $1.25 billion settlement and licence agreement deal with Forward Pharma were in the recent IP headlines